Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin A studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin AVitamin A (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ ARDS 100% Improvement Relative Risk Vitamin A for COVID-19  Mandour et al.  Sufficiency Are vitamin A levels associated with COVID-19 outcomes? Prospective study of 60 patients in Egypt (September 2021 - April 2022) Lower ARDS with higher vitamin A levels (p=0.001) c19early.org Mandour et al., The Egyptian J. Bronch.., Jul 2023 Favors vitamin A Favors control

Evaluation of vitamin A and E deficiency with severity of SARS-COV-2 disease: a case–control study

Mandour et al., The Egyptian Journal of Bronchology, doi:10.1186/s43168-023-00210-9, NCT05946499
Jul 2023  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin A for COVID-19
39th treatment shown to reduce risk in June 2023
 
*, now known with p = 0.031 from 13 studies.
Lower risk for recovery and cases.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments. c19early.org
Case control study with 30 ICU COVID-19 patients, 30 hospitalized non-ICU patients, and 30 matched healthy controls, showing vitamin A levels associated with COVID-19 and severity, with ICU patient levels < hospitalized patients < healthy controls. Authors also show significantly lower risk of ARDS with vitamin A levels above 0.65µg/ml.
risk of ARDS, 99.7% lower, OR 0.003, p < 0.001, cutoff 0.65μg/ml, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Mandour et al., 21 Jul 2023, prospective, Egypt, peer-reviewed, 5 authors, study period September 2021 - April 2022, trial NCT05946499 (history). Contact: balsam.sherif@kasralainy.edu.eg.
This PaperVitamin AAll
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit